FDA inspection
Bayer Healthcare Pharmaceuticals Inc.: FDA inspection ending Sep 24, 2013
FDA inspection 849853 · No Action Indicated (NAI) · Whippany, NJ
Key facts
| Inspection ID | 849853 |
|---|---|
| Firm | Bayer Healthcare Pharmaceuticals Inc. |
| FEI number | 2243252 |
| Address | 100 Bayer Blvd |
| City | Whippany |
| State | NJ |
| ZIP | 07981 |
| Country | United States |
| Fiscal year | 2013 |
| Inspection end date | Sep 24, 2013 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data